Several cardiac diseases, like supra-ventricular arrhythmias, myocardial infarction, left ventricular remodelling with aneurysms and heart valve diseases like mitral valve stenosis, infective endocarditis and prosthetic heart valves predispose to intracavitary thrombus generation, which is the main source for peripheral embolism. Often the main unifying risk factor for cardio-embolism is atrial fibrillation (AF) and many of these cardio-embolic complications are transient ischemic cerebrovascular attacks or strokes with various levels of residual compromise. Cardiac imaging with different techniques and modalities has the potential to effectively stratify thrombo-embolic risk in patients with AF and other cardiac comorbidities. In this review we tried to characterize the current clinical role of different cardiac imaging methods, specifically echocardiography, cardiac computed tomography and cardiovascular magnetic resonance, in identifying cardio-embolic risk factors and guiding antithrombotic therapy, with a particular attention to novel patents and future developments of these techniques.
Keywords: Atrial fibrillation, cardio-embolic, computed tomography, echocardiography, magnetic resonance imaging, thrombus, transesophageal.
Anti-epileptic Drug (AED) Use in Subarachnoid Hemorrhage (SAH) and Intracranial Hemorrhage (ICH)
Current Pharmaceutical Design Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Intraventricular Recombinant Tissue Plasminogen Activator in Treatment of Aneurysmal Intraventricular Hemorrhage: A Meta-Analysis
Current Drug Targets Patient-Specific Modeling and Multi-Scale Blood Simulation for Computational Hemodynamic Study on the Human Cerebrovascular System
Current Pharmaceutical Biotechnology An Evidence-Based Review of Off-Label Uses of Polidocanol
Current Clinical Pharmacology Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Drug Therapy for Abdominal Aortic Aneurysms Utilizing Omega-3 Unsaturated Fatty Acids and Their Derivatives
Current Drug Targets Serum Calprotectin as a Novel Biomarker in Abdominal Aortic Aneurysm Pathogenesis and Progression: Preliminary Data from Experimental Model in Rats
Current Vascular Pharmacology Angiotensin II and Abdominal Aortic Aneurysms: An update
Current Pharmaceutical Design Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases
Current Pharmaceutical Design Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge
Vascular Disease Prevention Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture
Current Pharmaceutical Design Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design Biological, Geometric and Biomechanical Factors Influencing Abdominal Aortic Aneurysm Rupture Risk: A Comprehensive Review
Recent Patents on Medical Imaging (Discontinued) Editorial (Thematic Issue: Novel Insights on Aortic Aneurysm)
Current Pharmaceutical Design CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets Outcome Prediction after Non-aneurysmal Non-traumatic Subarachnoid Hemorrhage
Current Neurovascular Research Ruptured Bronchial Artery Aneurysm Treated With Aortic Stent Graft and Aneurysm Embolization
Current Medical Imaging Contributory Role of Matrix Metalloproteinases in Cardiovascular Remodeling
Current Drug Targets - Cardiovascular & Hematological Disorders Anaerobic Bacteria as a Cause of Mycotic Aneurysm of the Aorta: Microbiology and Antimicrobial Therapy
Current Cardiology Reviews